How Common Are Finasteride Side Effects? The Real Numbers

Finasteride side effects are less common than most people expect. In clinical trials involving thousands of men taking the 1 mg dose for hair loss, roughly 2 to 4 percent experienced sexual side effects, compared to about 2 percent in the placebo group. That means the drug itself accounts for only a small additional risk beyond what people experience from expectation alone. Still, the side effects are real, and understanding the specific numbers can help you weigh the decision clearly.

Sexual Side Effects by the Numbers

The most-studied side effects of finasteride are sexual in nature: reduced libido, erectile difficulty, and changes in ejaculation. Two large one-year trials of 1,553 men found that 4.2 percent of those on finasteride 1 mg reported at least one sexual side effect, compared to 2.2 percent on placebo. A separate set of Phase III trials with 1,879 men showed nearly identical results: 3.8 percent on finasteride versus 2.1 percent on placebo.

Breaking those numbers down individually:

  • Decreased libido: about 1.8 to 1.9 percent on finasteride versus 1.3 percent on placebo
  • Erectile difficulty: about 1.3 to 1.4 percent versus 0.7 to 0.9 percent on placebo
  • Ejaculation changes: about 1.0 to 1.2 percent versus 0.4 to 0.7 percent on placebo

These are the rates for the 1 mg hair loss dose. The 5 mg dose prescribed for enlarged prostate carries higher rates. In one two-year study of 613 men on the 5 mg dose, 15.8 percent reported erectile problems (versus 6.3 percent on placebo) and 7.7 percent reported ejaculation issues (versus 1.7 percent on placebo). So which dose you’re taking matters significantly.

A 2017 study of 3,177 men on the 1 mg dose found a side effect incidence of just 0.7 percent. And a large review covering 17 trials and over 17,000 patients found that while men taking finasteride for enlarged prostate showed a clear statistical increase in sexual problems, men taking it for hair loss did not reach statistical significance. The lower dose genuinely appears to carry a lower risk.

How Much of This Is the Nocebo Effect?

One of the most striking findings in finasteride research involves what happens when men are told about the sexual side effects beforehand. In a controlled study, 120 men with enlarged prostate all received finasteride 5 mg, but half were informed about the drug’s potential sexual effects while the other half were simply told they were taking “a compound of proven efficacy.” The difference was dramatic.

Among the men who weren’t told about sexual side effects, 11.5 percent reported some form of sexual difficulty. Among those who were counseled about the risks, 43.6 percent reported problems. Erectile difficulty jumped from 9.6 percent to 30.9 percent, and decreased libido went from 7.7 percent to 23.6 percent. Same pill, same dose, very different outcomes based purely on expectation. This doesn’t mean finasteride side effects are imaginary. It does mean that anxiety about the drug amplifies the experience considerably, and the true drug-attributable risk is smaller than many online discussions suggest.

Breast Tissue Changes

Finasteride can cause breast tenderness or mild breast enlargement because it alters the balance between testosterone and estrogen. For the 5 mg dose, studies show gynecomastia (breast tissue growth) in about 4 percent of users compared to 2.4 percent on placebo. Breast tenderness occurs in roughly 0.8 percent versus 0.25 percent on placebo. These rates are lower at the 1 mg dose, though precise numbers from large trials are harder to isolate.

Mood Changes and Depression

Finasteride can affect mood. The European Medicines Agency has confirmed that the drug can cause depressed mood, depression, and in rare cases, suicidal thoughts. A review of safety reports identified 313 cases of suicidal ideation potentially linked to finasteride across an estimated 270 million patient-years of use. That translates to an extremely low absolute rate, but the consequences are serious enough that regulators have added warnings to the drug’s labeling.

The connection between sexual dysfunction and mood is also recognized. Some men experience mood changes that stem from or are worsened by the sexual side effects themselves, creating a cycle that can be hard to untangle. If you have a personal history of depression or suicidal thoughts, that’s important information to share with a prescriber before starting finasteride.

What Happens Over Years of Use

Long-term data is reassuring for most users. A Japanese study tracked men on finasteride for over ten years across three separate investigations. Adverse reaction rates were 0.7 percent over 2.5 years in a group of 3,177 men, and 6.8 percent over a full decade in a smaller group of 532. All adverse reactions were rated as mild, and nearly all patients continued treatment for the full ten-plus years. The investigators reported no cases of the persistent symptom cluster sometimes called “post-finasteride syndrome.”

That said, the existence and nature of persistent side effects after stopping the drug remains a genuine area of debate. While the large controlled studies show side effects resolving, some men report ongoing symptoms. Regulatory agencies have updated product labels to acknowledge this possibility, even as the clinical trial data suggests it is uncommon.

How Quickly Side Effects Resolve

For the majority of men who do experience side effects, symptoms typically clear within about two weeks of stopping the medication. Finasteride has a short half-life and is eliminated from the body quickly. If you notice sexual or mood-related changes that concern you, stopping the drug is a straightforward option, and you don’t need to taper off. If symptoms persist beyond two weeks after your last dose, that warrants a conversation with your provider.

Putting the Risk in Perspective

The gap between the finasteride group and the placebo group in major clinical trials is consistently small, on the order of 1 to 2 percentage points for any individual sexual side effect at the 1 mg dose. That means for every 100 men who take finasteride for hair loss, roughly 1 to 2 will experience a sexual side effect they would not have had on a sugar pill. The vast majority of users, well over 95 percent, report no problems at all.

Your baseline matters too. Men who are already anxious about side effects, or who read extensively about them before starting, report significantly higher rates of problems, as the nocebo research shows. This doesn’t mean you should ignore real symptoms, but it does suggest that the framing you bring to the medication can meaningfully influence your experience of it.